Skip to main content
Elsevier
View Cart
My account

Books in Diabetes

BooksJournals

    • Quick Guide to Diabetes Mellitus

      • 2nd Edition
      • March 1, 2026
      • William Winter E + 3 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 7 2 5 8
      • eBook
        9 7 8 0 4 4 3 2 1 7 2 4 1
      Quick Guide to Diabetes Mellitus, Second Edition provides essential knowledge on the pathophysiology, etiology, epidemiology, diagnosis, laboratory evaluation, and basic clinical management of diabetes and its complications targeted to laboratory scientists and technicians. Eleven percent of the U.S. population have been diagnosed with diabetes mellitus, and laboratory scientists play an essential role in the diagnosis, monitoring, and management of this disease. This reference presents an easy-to-read question-and-answer format that will provide fundamental knowledge and aid in commonly encountered clinical challenges.This updated release includes new information on genetic and environmental risk factors for type 1 and 2 diabetes, pediatric glucose targets per American Diabetes Association Standards, type 2 diabetes management sections, including treatment guidelines and information on glucagon-like peptide-1 receptor agonists and gastric bypass surgery.

    • The Story of GLP-1

      • 1st Edition
      • March 1, 2026
      • Jens Juul Holst
      • English
      • Hardback
        9 7 8 0 4 4 3 3 3 2 8 7 6
      • eBook
        9 7 8 0 4 4 3 3 3 2 8 8 3
      The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity is a critically acclaimed account detailing the groundbreaking discovery of the hormone GLP-1, narrated by the award-winning scientist Professor Jens Juul Holst, along with co-authors Professor Sten Madsbad, Professor Jens Meldgaard Bruun, and Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation. GLP-1 is the hormone found in weight loss medications and diabetes treatments such as Ozempic and Wegovy. The discovery of GLP-1 has significantly transformed treatment options for individuals with type 2 diabetes and obesity, offering benefits that include improved blood glucose regulation and substantial weight loss, while also lowering the risk of related complications. Professor Jens Juul Holst, MD, DMSc, is among the world's leading diabetes researchers, having pioneered the discovery of GLP-1 in the 1980s. In this book, we follow the historical research journey that led to the identification of this hormone, which now signifies a paradigm shift in the management of diabetes and obesity. "The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity" narrates the rising rates of obesity and diabetes, underscoring a critical public health issue, even in light of considerable progress in treatment alternatives. While traditional approaches, such as low-calorie diets, have shown potential for short-term weight loss, maintaining that loss has proven difficult. Efforts to achieve better blood sugar control have not consistently translated into reduced complications or improved patient outcomes, as demonstrated by extensive international studies. However, the introduction of new diabetes medications, particularly those based on glucagon-like peptide-1 (GLP-1), such as liraglutide and semaglutide, has marked a significant breakthrough. These medications not only improve blood sugar levels but also promote substantial weight loss and reduce cardiovascular complications, offering hope for better management of obesity and diabetes. Despite these promising results, challenges remain regarding accessibility and affordability of these treatments, raising important societal questions about who should receive them and how they should be funded. The author's involvement in the discovery and development of GLP-1 provides a unique perspective on the historical and physiological context of these advancements, making this book a valuable resource for understanding the complexities of metabolic diseases and the evolution of treatment options.

    • Chronic Complications of Diabetes Mellitus

      • 1st Edition
      • March 21, 2024
      • Didac Mauricio + 1 more
      • English
      • Paperback
        9 7 8 0 3 2 3 8 8 4 2 6 6
      • eBook
        9 7 8 0 3 2 3 9 0 4 4 3 8
      Chronic Complications of Diabetes Mellitus: Current Outlook and Novel Pathophysiological Insights provides a holistic view of the disease, discussing not only its classical complications but also the under recognized and managed conditions associated with diabetes. Chapters also discuss advances in our understanding of the genomic architecture of diabetes complications and how precision medicine can be used to personalize their management. Endocrinologists, diabetologists, primary care physicians and researchers interested in complications of diabetes mellitus and cutting-edge information will find this to be a comprehensive tome on the topic. Diabetes complications include pathological changes usually related to the vascular system and classical target organs. However, there are also nonclassical complications independent or partially independent from vascular damage that are often overlooked.

    • Environmental Pollution and Type 2 Diabetes Mellitus

      • 1st Edition
      • May 10, 2024
      • Sultan Ayoub Meo
      • English
      • Paperback
        9 7 8 0 4 4 3 2 1 6 4 6 6
      • eBook
        9 7 8 0 4 4 3 2 1 6 4 7 3
      Environmental Pollution and Type 2 Diabetes Mellitus elucidates on the global impact of environmental pollution and how it increases diabetes mellitus. Swift urbanization and the industrial revolution have increased environmental pollution to a hazardous level. Environmental pollution is a leading risk factor for several well-known diseases. This book opens venues for students, physicians, researchers, the science community, and policymakers to enhance their knowledge about environmental pollution, weather conditions, climate change, and their impact on insulin resistance and mechanisms allied to Type 2 diabetes mellitus (T2DM).Moreover, this book will provide knowledge about the green space environment and its impact on T2DM.

    • Diabetes Digital Health, Telehealth, and Artificial Intelligence

      • 1st Edition
      • June 14, 2024
      • David C. Klonoff + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 3 2 4 4 5
      • eBook
        9 7 8 0 4 4 3 1 3 2 4 3 8
      Diabetes Digital Health, Telehealth, and Artificial Intelligence explains how to develop and use the emerging technologies of digital health, telehealth, and artificial intelligence to address this important public health problem to deliver new hardware, software, and processes. The book explores trends in developing and deploying the three most important emerging technologies for diabetes: digital health, telehealth, and artificial intelligence. This book is essential to clinicians, scientists, engineers, industry professionals, regulators, and investors, offering the tools that will be used to create the next generation products to support a precision medicine approach to manage diabetes.According to the CDC, in the US there are 37 million people with diabetes and 96 million people with prediabetes. Diabetes triples the risk of myocardial infarction and stroke and is the leading cause of blindness, end stage renal failure, and amputations. The management of diabetes is becoming increasingly dominated by digital health tools consisting of wearable sensors, mobile applications providing decision support software, and wireless communication tools. Digital health provides new data streams that can be combined to create unique approaches for diabetes based on a precision medicine paradigm.

    • Biochemical Immunology of Diabetes and Associated Complications

      • 1st Edition
      • March 15, 2024
      • Pratima Tripathi + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 3 1 9 5 0
      • eBook
        9 7 8 0 4 4 3 1 3 1 9 6 7
      Biochemical Immunology of Diabetes and Associated Complications offers in-depth coverage of the association of biochemical and immunological aspects of the human body in diabetes. It discusses the suppression and modulation of the immune system and the impact of immunochemicals on the biochemical pathways in diabetes, along with associated complications. The book enumerates the exigency in knowledge about the immunomodulators as therapeutic targets to cure the syndrome. It will serve as an important reference for medical practitioners, researchers, medical students, masters and doctoral students. In addition, it could also be used as a reference for science graduates, science teachers, and researchers.

    • Myopathies and Tendinopathies of the Diabetic Foot

      • 1st Edition
      • September 10, 2024
      • Claude Pierre-Jerome
      • English
      • Hardback
        9 7 8 0 4 4 3 3 3 9 7 7 6
      • eBook
        9 7 8 0 4 4 3 1 3 3 2 9 9
      Myopathies and Tendinopathies of the Diabetic Foot: Anatomy, Pathomechanics, and Imaging is a unique reference of valuable instructive data that reinforces the understanding of myopathies and tendinopathies related to diabetes-induced Charcot foot. Diabetic myopathies usually precede other complications (i.e., deformity, ulceration, infection) seen in the diabetic foot. Oftentimes, these myopathies may be isolated especially during their initial stage. In the absence of clinical information relevant to diabetes, the solitaire occurrence of myopathies may lead to confusion, misinterpretation, and misdiagnosis. The misdiagnosis can cause delay of management and consequent high morbidity. This book emphasizes the complications of diabetic myopathies and tendinopathies and all their aspects, including pathophysiology, pathomechanics, imaging protocols, radiological manifestations, histological characteristics, and surgical management.Diabetes type II and its complications (diabetic myopathies and tendinopathies) have reached a dreadful high incidence worldwide. Likewise, the need for better understanding of these complications becomes indispensable. In this book, the readers of all genres will find all they need to know about these conditions. This book serves as a classic academic reference for educators, healthcare specialists, healthcare givers, and healthcare students.

    • Insulin

      • 1st Edition
      • January 18, 2024
      • Andrew J. Krentz
      • English
      • Paperback
        9 7 8 0 3 2 3 9 1 7 0 7 0
      • eBook
        9 7 8 0 3 2 3 9 8 5 6 9 7
      Insulin: Deficiency, Excess and Resistance in Human Disease provides an overview of the role of insulin in the pathogenesis of prevalent non-communicable diseases such as obesity, type 2 diabetes, cardiovascular disease, and cancer, along with a comprehensive review of insulin replacement therapies and novel cardioprotective and insulin-sensitizing drugs. Notable advances in precision diagnosis and therapy for single gene subtypes of diabetes in recent years are also discussed.The discovery of insulin and its lifesaving introduction into clinical practice is one of the most celebrated accomplishments of medical science. However, despite decades of progress and major technical advances, the goal of providing insulin replacement therapy that truly mimics normal physiology remains elusive.

    • Tutorials in Clinical Chemistry

      • 1st Edition
      • October 10, 2023
      • Ibrahim A. Hashim
      • English
      • Paperback
        9 7 8 0 1 2 8 2 2 9 4 9 1
      • eBook
        9 7 8 0 1 2 8 2 2 9 1 8 7
      Tutorials in Clinical Chemistry is designed for trainee pathology residents, clinical chemists, medical students, and clinical laboratory scientists, in addition to those preparing for board and postgraduate examination. It is helpful to those in training as well as a teaching aid for mentors, faculty, and directors. The book is organized into 17 system-based chapters covering essential pathophysiology, biochemical investigation, and technical aspects of relevance to results interpretation. Tutorials in Clinical Chemistry is a must-have, didactic and essential knowledge as well as practical resource for learning and review.

    • Metabolic Syndrome

      • 1st Edition
      • November 10, 2023
      • Satinath Mukhopadhyay + 1 more
      • English
      • Paperback
        9 7 8 0 3 2 3 8 5 7 3 2 1
      • eBook
        9 7 8 0 3 2 3 8 5 6 5 8 4
      Metabolic Syndrome: From Mechanisms to Interventions covers all aspects of this complex and multifactorial disease, providing a cutting-edge understanding of the problem of MetS, with a particular focus on its prevention and clinical management. The book discusses practical implementable approaches to its reversal in clinical practice, encompassing the entire spectrum of MetS, from molecular understanding to clinical therapeutics and prevention. This book is a valuable resource for clinicians in multiple specialties, including endocrinologists, diabetologists, hepatologists, gynecologists and researchers in related fields who need a deep understanding of the full range of scientific and clinical aspects of metabolic syndrome.